Prelude Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Prelude Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-126,701	Closed	-$2.65M	–	1989
2016 Q3	$2.65M	Buy	+126,701	New	+$1.46M	0.28%	68

Prelude Capital Management's VTAE Position: Q4 2016 in Review

Prelude Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 126,701 shares — an estimated $2.65M sold.

Prelude Capital Management first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $2.65M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Prelude Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Prelude Capital Management sold 126,701 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $2.65M.
Prelude Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Prelude Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $2.65M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Prelude Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.